Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001–2012

Highlights • PCVs coverage increased from 56% in those born in 2004 to 94% in those born in 2008. • After PCV7, IPD decreased in children

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2015-01, Vol.33 (2), p.359-366
Hauptverfasser:	Lepoutre, A, Varon, E, Georges, S, Dorléans, F, Janoir, C, Gutmann, L, Lévy-Bruhl, D
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Allergy and Immunology Child Child, Preschool Female France France - epidemiology Heptavalent Pneumococcal Conjugate Vaccine - administration & dosage Hospitals Humans Immunization Incidence Infant Infant, Newborn Invasive pneumococcal disease Laboratories Male Meningitis Middle Aged Pneumococcal conjugate vaccines Pneumococcal Infections - prevention & control Pneumococcal Vaccines - administration & dosage Pneumonia Population Surveillance Serogroup Serotype replacement Serotyping Streptococcus pneumoniae Time Factors Vaccination Vaccine impact Vaccines Vaccines, Conjugate - administration & dosage Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • PCVs coverage increased from 56% in those born in 2004 to 94% in those born in 2008. • After PCV7, IPD decreased in children
ISSN:	0264-410X 1873-2518
DOI:	10.1016/j.vaccine.2014.11.011